INTRODUCTION
Colorectal cancer (CRC) is one of the most common cancers and the second leading cause of cancer-related death worldwide. At diagnosis, 14.5-25% of CRC patients have synchronous liver metastasis, and another 25-30% of CRC patients will develop liver metastasis during the next 2-3 years (1-4). The liver is the most common site of metastases, and liver metastasis is responsible for the death of at least two thirds of patients with a colorectal malignancy (5, 6) . Early diagnosis of colorectal liver metastases (CLM) is important in terms of overall survival, and metastasis is the major cause of death in patients with CRC and its prevalence has been shown to depend on tumor stage (7) . During the last few decades, resection of liver-limited CLM has been increasingly accepted by surgeons and oncologists, and improvements observed in outcome appear to be associated with increased use of hepatic resection or ablation therapy (8, 9) . Some studies conducted in patients who have undergone complete surgical resection of liver metastases suggest that overall survival rates exceed 50% at 5 years and range from 17% to 25% at 10 years (10) (11) (12) . Although neo-adjuvant chemotherapy has the potential to convert initially unresectable disease into resectable disease in some patients, the frequency of conversion and overall survival remain relatively low. It was reported that in patients with initially unresectable CLM, the 3-year overall survival rate was 30% after chemotherapy, and the median survival times were 24.4 and 25.8 months in cetuximab or bevacizumab combined with chemotherapy groups, respectivePurpose: The aim of this study was to determine the radiologic risk factors of colorectal cancer (CRC) with synchronous liver metastases. Materials and Methods: A total of 197 patients with CRC who had a visible tumor on contrast-enhanced abdominopelvic computed tomography and were treated between January 2012 and December 2012 were included. Longitudinal diameter, mural thickness, primary tumor attenuation, and other metastases were evaluated independently. Univariate analysis and multivariate logistic regression analysis were used to identify risk factors associated with the presence of liver metastases. Results: Cases were divided into two groups based on the presence or absence of liver metastases (n = 56 and 141, respectively). Primary tumors with enhancement of ≥ 90 Hounsfield units (HU) were found to have a higher risk of liver metastases than those with enhancement of < 90 HU [odds ratio (OR): 2.619, p = 0.034]. The presence of pulmonary metastases was associated with a higher risk of liver metastases (OR: 14.218, p = 0.025). The presence of lymph node metastases (N2 vs. N0) and carcinoembryonic antigen (CEA) level independently predicted the presence of liver metastases (OR: 8.766, p < 0.001; OR: 1.012, p = 0.048).
Conclusion:
The identified risk factors of synchronous liver metastases in CRC were tumor mural enhancement, pulmonary metastases, lymph node metastases, and CEA level. ly (13, 14) .
Index terms
Previous studies have reported that mesorectal vascular and fascia invasion by rectal magnetic resonance imaging (MRI) in rectal cancer patients independently predict early metastases (15, 16) , and thus, it was suggested that liver MRI should be performed at diagnosis in high risk patients. Recently, a clinical trial (SERENADE) was initiated to determine the usefulness of DW-MRI for screening synchronous liver metastases in high risk primary CRC patients (17). However, in colon cancer, computed tomography (CT) continues to be used for risk analysis, because abdominal MRI for colon cancer is limited by respiration control and motion artifact. Furthermore, little information is available regarding the risk factors of liver metastasis in CRC patients as determined by CT. Accordingly, we undertook the present study to identify predictors of the presence of synchronous liver metastases in CRC.
MATERIALS AND METHODS
This retrospective study was approved by our Institutional Review Board, which waived the requirement for obtaining informed consent (GAIRB 2017-195) .
Patient Population
We retrospectively reviewed our institutional electronic medical database of 364 patients with pathologically proven adenocarcinoma of the colon and rectum who were diagnosed between January 2012 and December 2012. One hundred sixty-seven patients were excluded for the following reasons: no visible measurable primary CRC on CT (n = 133); no preoperative CT scan (n = 3); refusal of further treatment at our institute (n = 14); and the presence of another primary cancer (n = 17). Finally, 197 patients were enrolled in this study (Fig. 1) .
CT Protocol
All patients underwent contrast-enhanced multi-detector CT 
MRI Protocol
MRI imaging was performed using a 1. Twelve patients with liver metastases were diagnosed by CT and PET/CT (size progression, n = 10; size reduction, n = 2). We reviewed the indeterminate hepatic lesions on CT or MRI and determined an equivocal case (per patient) by consensus. An equivocal case was defined as the one in which the two readers could not determine whether the patient had liver metastases or not. Synchronous liver metastases were defined as liver metastases detected by preoperative CT or MRI or during primary tumor resection (28) .
Statistical Analysis
Categorical data are presented as percentages, frequencies, and differences between proportions, and they were compared using the chi-squared test or Fisher's exact test, as appropriate.
Continuous data with a significantly skewed distribution are expressed as medians, and they were compared using the Mann- 
RESULTS

Patient Demographics
The demographics of patients with CRC and liver mass are shown in Tables 1, 2 . Of the 197 patients, 56 (28.4%) had detectable synchronous liver metastases; 31 (55%) had metastasis confined to the liver and 25 (45%) had metastasis to another organ.
Thirty-one (31/56, 55%) patients underwent CT only and 25 (25/56, 45%) patients underwent both CT and MRI. Among the patients who underwent CT alone, only one patient was an equivocal case. This equivocal lesion was not detected in the initial CT interpretation in real clinical practice and additional MRI was not performed. In the present study, this lesion was not detected by either reader during retrospective CT evaluation. However, this lesion had increased in size on the follow-up CT scan after 9 months and it was confirmed to be metastasis (Fig. 3) . tastasis on MRI, and the other 14 lesions were interpreted as benign hepatic lesions. Three patients had small liver metastases which were detected by MRI but not by CT (Fig. 4) . However, among them, there were no equivocal cases because they had other definite liver metastases.
Results of Image Analysis
The CT findings of primary tumors are summarized in Table   3 . Longitudinal diameter, mural thickness, and enhancement were significant higher in patients with liver metastases than in patients without liver metastases (p < 0.05). With respect to lesion shape, 23% (13/56) of patients with liver metastases exhibited a bulky pattern, whereas 23% (33/141) of patients without liver metastases had intraluminal polypoid lesions (p < 0.001).
With respect to pericolic fat infiltration, 77% (43/56) of patients with liver metastases exhibited nodular or linear infiltration, whereas 49% (69/141) of patients without liver metastases exhibited hazy infiltration or absence of infiltration. Fourteen (25%, 14/56) patients with liver metastases had pulmonary metastases, whereas only one patient (0.7%, 1/141) without liver metastases had pulmonary metastases (p < 0.001).
Univariate and Multivariate Analyses
Univariate analysis showed that the risk factors associated with Table 5) .
Diagnostic Performance
Lymph node metastases showed the largest area under the ROC curve (0.818, p < 0.001) (Fig. 5, Table 6 ). Also, lymph node 
DISCUSSION
This study demonstrated that primary CRC enhancement, the presence of pulmonary metastasis, N2 stage, and CEA level significantly predicted the presence of synchronous liver metas- tases. Our results suggest that radiologists should be more concerned about small hepatic lesions and should not hesitate to request MRI or percutaneous needle biopsy when equivocal hepatic lesions are encountered, and that surgeons should concentrate on small hepatic lesions during laparotomy in CRC patients with high risk factors. Furthermore, we recommend that retrospective reviews should be conducted for missed hepatic lesions and follow-ups should be conducted more frequently in such patients.
Primary tumor enhancement has not been well evaluated, and the results of the present study suggested the possibility of a correlation between higher tumor enhancement and liver metastases. However, previous studies have reported contrary results. In one study, the researchers showed that among CT perfusion parameters, the mean blood flow, which reflects the flow rate through the vasculature, was found to be related to tumor vascularity, and it was found to be lower in poorly differentiated tumors than in well differentiated or moderately differentiated tumors (18) . Another study concluded that poorly perfused tumors have poorer outcomes (29) . These discrepancies may have been caused by the ROI measurement method used in the present study, as we located ROIs in the area of greatest enhancement, which cannot accurately reflect intratumoral heterogeneity. When we examined the correlation between attenuation and cell type, no relation was found. We supposed that the number of patients with mucinous adenocarcinoma was too small to obtain appropriate statistical power.
The strong relation between pulmonary metastases and liver and in turn, lung metastasis may then act as the centrum for further dissemination (31) . This hypothesis is supported by necropsy data of adenocarcinoma of the upper rectum and that of other carcinomas in the digestive system (31, 32) .
We found that N2 stage disease presents a higher risk of liver metastases than N0 stage disease. A prospective, large population-based study showed that lymph node metastasis was an independent risk factor of synchronous liver metastases in CRC (33) . However, recent studies have shown that radiologic lymph node metastases from rectal MRI did not significantly predict liver metastases (16, 34) . Further studies are evidently needed for assessing radiologic lymph node metastases in CRC.
Use of chemotherapy and the proportion of patients who undergo hepatic surgery continue to increase and these factors have significantly increased the survival rates (8) . Furthermore, retrospective studies conducted in patients who have undergone complete surgical resection of liver metastasis have suggested that resection improves the overall survival rates. Thus, early and accurate detection of liver metastases is clinically important because it can significantly affect the choice of therapeutic approach and prognosis. However, little is known regarding the prevalence of synchronous liver metastases in CRC and few epidemiologic studies have addressed the overall metastasis rate in CRC. There is some concern that multiple detector computed tomography (MDCT) images may not accurately characterize small hepatic nodules or sufficiently differentiate small liver metastases and small hepatic cysts or hemangiomas (35) (36) (37) . Furthermore, MDCT is less able to detect liver metastases than MRI when an extracellular contrast agent is used (38, 39) . In addition, as we have mentioned above, ROI-based assessment cannot adequately reflect intratumoral heterogeneity, and the selection of ROI locations introduces a possible bias. We suggest that further studies should be conducted to refine the measurements of whole tumor volume enhancement.
In conclusion, our findings suggest that tumor enhancement and the presence of pulmonary metastases as determined by MDCT could be used to predict the risk of development of synchronous liver metastases in CRC patients. We suggest that equivocal hepatic lesions should be assessed thoroughly for metastases in patients with high risk factors.
